镁耗竭评分与美国成人代谢综合征:2003至2018年NHANES分析
基于美国国家健康与营养调查(NHANES)2003至2018年15565名成人数据,分析肾脏重吸收相关镁耗竭评分(MDS)与代谢综合征(MetS)的关联。多变量分析显示,MDS每增加1个单位,MetS风险约增加30%(OR 1.31;95%CI 1.17-1.45),呈线性剂量反应关系,且不受年龄、性别、种族、肥胖、吸烟或饮酒影响。作者认为较高的尿镁丢失可能是美国成人MetS的独立线性危险因素。
要点
- MDS每增加1个单位,MetS风险约增加30%(OR 1.31;95%CI 1.17-1.45)。
- MDS与MetS呈线性剂量反应关系,各亚组间无显著交互作用。
- 作者认为优化镁营养状态可能对MetS患者有益。
核心结论
- 较高的尿镁丢失(以MDS量化)可能是美国成人MetS的独立线性危险因素,不受社会人口学和行为因素影响。
- 作者认为优化镁营养状态可能对MetS患者有益。
研究设计与样本
- 分析NHANES 2003至2018年15565名成人数据。
- MetS依据美国国家胆固醇教育计划成人治疗组III报告定义。
- MDS是用于预测镁缺乏状态的评分系统,充分考虑影响肾脏重吸收能力的病理生理因素。
- 采用加权单变量和多变量logistic回归评估MDS与MetS的关联,并进行限制性立方样条分析和按社会人口学及生活方式因素的分层分析。
主要发现
- 单变量和多变量分析中,较高的MDS均与MetS odds增加显著相关。
- MDS每增加1个单位,MetS风险约增加30%(OR 1.31;95%CI 1.17-1.45),即使调整混杂因素后仍如此。
- 限制性立方样条图显示MDS范围内呈线性剂量反应关系。
- 该正相关在各人群亚组中保持一致,按年龄、性别、种族、肥胖、吸烟状态或饮酒量均无显著交互作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The association between magnesium status and metabolic syndrome (MetS) remains unclear. OBJECTIVE: This study aimed to examine the relationship between kidney reabsorption-related magnesium depletion score (MDS) and MetS among US adults. METHODS: We analyzed data from 15 565 adults participating in the National Health and Nutrition Examination Survey (NHANES) 2003 to 2018. MetS was defined according to the National Cholesterol Education Program's Adult Treatment Panel III report. The MDS is a scoring system developed to predict the status of magnesium deficiency that fully considers the pathophysiological factors influencing the kidneys' reabsorption capability. Weighted univariate and multivariable logistic regression were used to assess the association between MDS and MetS. Restricted cubic spline (RCS) analysis was conducted to characterize dose-response relationships. Stratified analyses by sociodemographic and lifestyle factors were also performed. RESULTS: In both univariate and multivariable analyses, higher MDS was significantly associated with increased odds of MetS. Each unit increase in MDS was associated with approximately a 30% higher risk for MetS, even after adjusting for confounding factors (odds ratio 1.31; 95% CI, 1.17-1.45). RCS graphs depicted a linear dose-response relationship across the MDS range. This positive correlation remained consistent across various population subgroups and exhibited no significant interaction by age, sex, race, adiposity, smoking status, or alcohol consumption. CONCLUSION: Higher urinary magnesium loss as quantified by MDS may be an independent linear risk factor for MetS in US adults, irrespective of sociodemographic and behavioral factors. Optimizing magnesium nutritional status could potentially confer benefits to patients with MetS.
引用
- Wang X, Zeng Z, Wang X, et al. Magnesium Depletion Score and Metabolic Syndrome in US Adults: Analysis of NHANES 2003 to 2018. J Clin Endocrinol Metab. 2024. PMID: 38366015. doi:10.1210/clinem/dgae075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。